Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 065424/0731 | |
| Pages: | 4 |
| | Recorded: | 11/01/2023 | | |
| Attorney Dkt #: | Q292750 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18499840
|
Filing Dt:
|
11/01/2023
|
|
Publication #:
|
|
Pub Dt:
|
02/22/2024
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT COMPRISING FUSION PROTEIN INCLUDING IL-2 PROTEIN AND CD80 PROTEIN AND ANTICANCER DRUG
|
|
|
Assignee
|
|
|
|
|
| A-1116, 167, SONGPA-DAERO, SONGPA-GU |
| SEOUL, KOREA, REPUBLIC OF 05855 |
|
|
Correspondence name and address
|
| |
SUGHRUE MION, PLLC
|
| |
2000 PENNSYLVANIA AVENUE, NW
|
| |
SUITE 900
|
| |
WASHINGTON, DC 20006-1811
|
Search Results as of:
09/23/2024 12:37 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
